1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2224–2260.
2.
Blann A, Lip G, Islim I, et al. Evidence of platelet activation in hypertension. J Hum Hypertens 1997; 11(9): 607–609.
3.
Camilletti A, Moretti N, Giacchetti G, et al. Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients. Am J Hypertens 2001; 14(4 Pt 1): 382–386.
4.
Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002; 13(5–6): 301–306.
5.
Pogorzelska K, Krtowska A, Krawczuk-Rybak M, et al. Characteristics of platelet indices and their prognostic significance in selected medical condition – a systematic review. Adv Med Sci 2020; 65(2): 310–315.
6.
Korniluk A, Koper-Lenkiewicz OM, Kamiska J, et al. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm 2019; 2019: 9213074.
7.
Bawore SG, Adissu W, Niguse B, et al. A pattern of platelet indices as a potential marker for prediction of pre-eclampsia among pregnant women attending a Tertiary Hospital, Ethiopia: A case-control study. PLoS ONE 2021; 16(11): e0259543.
8.
Surgit O, Pusuroglu H, Erturk M, et al. Assessment of mean platelet volume in patients with resistant hypertension, controlled hypertension and normotensives. Eurasian J Med 2015; 47(2): 79–84.
9.
Pusuroglu H, Cakmak HA, Erturk M, et al. Assessment of the relation between mean platelet volume, non-dipping blood pressure pattern, and left ventricular mass index in sustained hypertension. Med Sci Monit 2014; 20: 2020–2026.
10.
Yang K, Tao L, Mahara G, et al. An association of platelet indices with blood pressure in Beijing adults: Applying quadratic inference function for a longitudinal study. Medicine (Baltimore) 2016; 95(39): e4964.
11.
Li T, Jin J, Meng Z, et al. The different associations between platelet distribution width and hypertension subtypes in males and females. Biosci Rep 2020; 40(11): BSR20201747.
12.
Vidal-Petiot E, Elbez Y, Lüscher TF, et al. The 2018 ESC-ESH guidelines for the management of arterial hypertension leave clinicians facing a dilemma in half of the patients. Eur Heart J 2018; 39(45): 4040–4041.
13.
Blann AD, Nadar S, Lip GY. Pharmacological modulation of platelet function in hypertension. Hypertension 2003; 42(1): 1–7.
14.
Li T, Meng Z, Zhang W, et al. No obvious association exists between mean platelet volume and hypertension subtypes. Biomark Med 2021; 15(8): 577–584.
15.
Sadeghi MT, Soroureddin Z, Nouri-Vaskeh M, et al. Association of the mean platelet volume and red cell distribution width with dipper and non-dipper blood pressure in prehypertensive non-smokers. BMC Res Notes 2019; 12(1): 824.
16.
Alpsoy Ş, Gökçek S, Özkaramanl Gür D, et al. The relationship between mean platelet volume and reverse dipping blood pressure pattern in patients with essential hypertension. Clin Exp Hypertens 2021; 43(7): 671–676.
17.
Wiwanitkit V. Plateletcrit, mean platelet volume, platelet distribution width: its expected values and correlation with parallel red blood cell parameters. Clin Appl Thromb Hemost 2004; 10(2): 175–178.
18.
Shanker S, Niranjana Murthy B. Plateletcrit – An important indicator of hypertension induced organ damage. RJ MAHS 2020; 3(2): doi: 10.46319/RJMAHS.2020.v03i02.001.
19.
Cetin N, Tufan AK. Platelet activation and inflammation in hypertensive children with non-dipper and dipper status. Iran J Kidney Dis 2019; 13(2): 105–112.
20.
Buch A, Kaur S, Nair R, et al. Platelet volume indices as predictive biomarkers for diabetic complications in type 2 diabetic patients. J Lab Physicians 2017; 9(2): 84–88.
21.
Waghale RM, Khot RS, Joshi PP. Platelet volume indices: markers of carotid atherosclerosis in type 2 diabetes mellitus? Clinical Diabetology 2020; 9(2): 103–111.
22.
Ji S, Zhang J, Fan X, et al. The relationship between mean platelet volume and diabetic retinopathy: a systematic review and meta-analysis. Diabetol Metab Syndr 2019; 11: 25.
23.
Chawla R, Sahu J, Punyani H, et al. Evaluation of platelet volume indices as predictive biomarkers of microvascular complications in patients with type 2 diabetes. Int J Diabetes Dev Ctries 2021; 41(1): 89–93.
24.
Demirtunc R, Duman D, Basar M. Effects of doxazosin and amlodipine on mean platelet volume and serum serotonin level in patients with metabolic syndrome. Clin Drug Investig 2007; 27(6): 435–441.
25.
Nadar S, Blann A, Lip G. Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy. Ann Med 2004; 36(7): 552–557.
26.
Stergiou GS, Palatini P, Parati G, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens 2021; 39(7): 1293–1302.
27.
Steen M, van der, Lenders J, Graafsma S, et al. Reproducibility of ambulatory blood pressure monitoring in daily practice. J Hum Hypertens 1999; 13(5): 303–308.
28.
Ates I, Bulut M, Ozkayar N, et al. Association between high platelet indices and proteinuria in patients with hypertension. Ann Lab Med 2015; 35(6): 630–634.
